CytoReason

PocDoc, Poolbeg Pharma, CytoReason, CE mark, Boots, Caterpillar
By  Tammy Lovell 02:36 am April 1, 2022
PocDoc secures CE mark for digital reader of lateral flow testing Cambridge-based startup PocDoc has secured a CE mark for its artificial intelligence (AI) driven digital reader of lateral flow tests. The cloud-based system allows any smartphone or tablet to become a universal digital reader, so healthcare organisations can roll out lateral flow testing for any disease or marker at scale.   Steve...
AI, IBD, drug discovery
By  Tammy Lovell 03:56 am May 19, 2021
Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease (IBD).  This is the first collaboration between the two companies, pairing Ferring’s medical expertise with CytoReason’s artificial intelligence (AI) platform to build cell-centred disease models.  CytoReason is developing a...